We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The World Health Organization (WHO) is seeking comments by February 28 on a draft policy on tracking and tracing drugs through the supply chain that would push globally for unit-level serial numbers. Read More
Drug distributor Acetris Health prevailed yesterday in an appeals court ruling that the company can call its products U.S.-made even though the active pharmaceutical ingredients are sourced elsewhere. Read More
In comments to the FDA, drugmakers called on the agency to clarify in its draft guidance for biosimilar and interchangeable insulin products that the agency will still hold applicants to the current licensing standards. Read More
The White House supports a bipartisan bill, S. 2543, that would impose fines on pharma companies that hike Medicaid drug prices high above the inflation rate. Read More
The Department of Justice plans to continue its investigation into anticompetitive activity in the generic drug industry, according to a senior DOJ official. Read More
The Trump administration’s fiscal 2021 budget proposal unveiled Monday seeks an increase of 4.5 percent for the FDA while cutting most other non-defense spending. Read More